Literature DB >> 22791724

Jaundice following intravesical botulinum toxin - a previously unreported complication.

R R Marri1, S J Bromage, A Darmalingum, C Calvert, G Banait, D A Jones, S Islam.   

Abstract

A 59-year-old woman presented 5 days after her third instillation of intravesical botulinum toxin with right upper quadrant pain and jaundice. Blood tests demonstrated deranged liver function tests. An abdominal ultrasound, radiograph, magnetic resonance cholangiopancreatography, serum hepatitis screen, immunoglobulins and autoantibody testing were normal. An ultrasound-guided liver biopsy was performed. The histological appearances were those of chronic active/lobular hepatitis. Following treatment with steroids, her jaundice improved over a period of about 3 weeks. Her serum liver function tests returned to normal in 3 months. The steroids were discontinued once her liver function tests normalised. The patient had no further recurrence of jaundice and serum liver function tests have been within normal limits after 6 months follow-up.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22791724      PMCID: PMC3028418          DOI: 10.1136/bcr.04.2010.2881

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Antibodies against botulinum neurotoxin type A as a cause of treatment failure after the first detrusor injection.

Authors:  Heinrich Schulte-Baukloh; Hans Bigalke; Gert Heine; Daniela Pape; Burkard Stuerzebecher; Kurt Miller; Helmut H Knispel
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

Review 2.  Botulinum toxin A in the overactive bladder: current status and future directions.

Authors:  Roger Dmochowski; Peter K Sand
Journal:  BJU Int       Date:  2007-02       Impact factor: 5.588

3.  Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

Authors:  J O'Donohue; K A Oien; P Donaldson; J Underhill; M Clare; R N MacSween; P R Mills
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 4.  Botulinum toxin for the treatment of lower urinary tract symptoms: a review.

Authors:  A Sahai; M Khan; C J Fowler; P Dasgupta
Journal:  Neurourol Urodyn       Date:  2005       Impact factor: 2.696

Review 5.  Review article: drug hepatotoxicity.

Authors:  C Y Chang; T D Schiano
Journal:  Aliment Pharmacol Ther       Date:  2007-05-15       Impact factor: 8.171

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.